These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15229387

  • 1. Effect of long-term angiotensin II type I receptor antagonism on peripheral and coronary vasomotion.
    Preumont N, Unger P, Goldman S, Berkenboom G.
    Cardiovasc Drugs Ther; 2004 May; 18(3):197-202. PubMed ID: 15229387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine.
    Matsuo S, Matsumoto T, Takashima H, Ohira N, Yamane T, Yasuda Y, Tarutani Y, Horie M.
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):164-70. PubMed ID: 15243296
    [Abstract] [Full Text] [Related]

  • 5. Candesartan improves impaired endothelial function in the human coronary artery.
    Iino K, Watanabe H, Iino T, Katsuta M, Koyama T, Kosaka T, Terui G, Ito H.
    Coron Artery Dis; 2012 Jun; 23(4):278-83. PubMed ID: 22343799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis.
    Prasad A, Halcox JP, Waclawiw MA, Quyyumi AA.
    J Am Coll Cardiol; 2001 Oct; 38(4):1089-95. PubMed ID: 11583887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. L-Arginine normalizes coronary vasomotion in long-term smokers.
    Campisi R, Czernin J, Schöder H, Sayre JW, Schelbert HR.
    Circulation; 1999 Feb 02; 99(4):491-7. PubMed ID: 9927394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET.
    Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valenta I, Aiello F, Fleischmann S, Alkadhi H, Kaufmann PA.
    J Nucl Med; 2006 Sep 02; 47(9):1420-6. PubMed ID: 16954548
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity.
    Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, Schelbert HR.
    Circulation; 1998 Jul 14; 98(2):119-25. PubMed ID: 9679717
    [Abstract] [Full Text] [Related]

  • 18. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration.
    Schindler TH, Nitzsche EU, Munzel T, Olschewski M, Brink I, Jeserich M, Mix M, Buser PT, Pfisterer M, Solzbach U, Just H.
    J Am Coll Cardiol; 2003 Sep 03; 42(5):814-22. PubMed ID: 12957426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation.
    Kristoffersen US, Wiinberg N, Petersen CL, Gerstoft J, Gutte H, Lebech AM, Kjaer A.
    Nucl Med Commun; 2010 Oct 03; 31(10):874-80. PubMed ID: 20700067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.